A population-based investigation analysing the effects of antidiabetic medications on the risk of pancreatic cancer in Korean patients has concluded that the exposure of sulfonylurea and insulin was related to increased risk of pancreatic cancer compared to subjects with no drug exposure [259]. This evidence concerns the gene INS and familial pancreatic carcinoma.